Amicus Therapeutics Inc (NASDAQ:FOLD)
| 12.81 Delayed Data As of Jun 09 |  +0.19 / +1.51%Today’s Change | 7.78 Today|||52-Week Range 13.84 | +4.91% Year-to-Date |
Latest FOLD News | Press Releases
| Why Is Amicus Therapeutics (FOLD) Up 8.1% Since Last Earnings Report? Jun 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 12.62 |
| Today’s open | 12.62 |
| Day’s range | 12.52 - 12.93 |
| Volume | 65,787 |
| Average volume (3 months) | 2,446,428 |
| Market cap | $3.5B |
Data as of 4:00pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +11.31% |
| Earnings growth (this year) | +46.91% |
| Earnings growth (next 5 years) | +65.42% |
| Revenue growth (last year) | +7.76% |
| P/E ratio | NM |
| Price/Sales | 10.72 |
| Price/Book | 27.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RAREUltragenyx Pharmaceu... | -0.22 | -0.43% |
| SAGESAGE Therapeutics In... | +2.88 | +5.08% |
| ---- | ||
| KRYSKrystal Biotech Inc | +0.94 | +0.73% |
Data as of 4:00pm ET, 06/09/2023
Financials
| Next reporting date | August 3, 2023 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $329.2M |
| Annual profit (last year) | -$236.6M |
| Net profit margin | -71.85% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Philadelphia, Pennsylvania |
Forecasts
